Anti-D Testing in Intravenous Immunoglobulins: Shouldn't It Be Considered?-Reference-Cited by-同舟云学术

Anti-D Testing in Intravenous Immunoglobulins: Shouldn't It Be Considered?

Published:1996-08 Issue:2 Volume:71 Page:132-132
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:

Author:

Pisani Giulio,Wirz Maria,Gentili Giuliano

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1423-0410.1996.7120132.x/fullpdf

Reference3 articles.

1. Hemolysis due to high-dose intravenous treatment for patients with idiopathic thrombocytopenic purpura;Nakamura;Acta Haematol,1986

2. Hemolysis following intravenous immune globulin therapy;Copelan;Transfusion,1986

3. Effect of intravenous immunoglobulin in immune thrombocytopenia: Competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells;Salama;Lancet,1986

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Certification of a Standard Sample for Determining Anti-D Antibody Contents in Human Immunoglobulin Preparations;Pharmaceutical Chemistry Journal;2020-06

2. Reference Materials Used for Specific Safety Evaluation of Human Immunoglobulin and Human Albumin Products: Features of Development, Certification and Application;Reference Materials in Measurement and Technology;2020

3. Reference materials used for specific safety evaluation of human immunoglobulin and human albumin products: features of development, certification and application;Reference materials;2019-04-02

4. Technological Aspects of Ensuring the Specific Safety of Human Immunoglobulin and Albumin Preparations;Pharmaceutical Chemistry Journal;2018-08

5. Reply;Transfusion;2009-10-20